Catheter Precision's LockeT Clinical Data Accepted for Publication in JICE Journal

Catheter Precision (NYSE American: VTAK) has announced that a research manuscript regarding its LockeT Suture Retention Device has been accepted for publication in the prestigious Journal of Interventional Cardiac Electrophysiology (JICE). The peer-reviewed study evaluates the safety and efficacy of the device specifically for large-bore venous access closure. This publication represents a significant clinical milestone for the med-tech company, providing essential third-party validation of its core technology. Market analysts view this development as a positive step toward broader market adoption and increased physician confidence in the device's performance. For investors, the peer-review process serves as a critical hurdle in establishing the long-term commercial viability of innovative medical devices. This clinical validation is expected to strengthen VTAK's competitive position within the cardiac electrophysiology sector.